Hepatology - European Medical Journal

This site is intended for healthcare professionals

Continue

Hepatology

Filter
24 Sep 2019

Suppression of stress-induced enzyme as therapeutic target for liver cancer

EXPRESSION of an enzyme as a stress-response upregulates significant proliferation pathways in the progression of liver cancer, according to a new study…
24 Sep 2019

Alcohol-Producing Gut Bacteria May Damage Liver

NON-ALCOHOLIC fatty liver disease (NAFLD) is characterised by the build-up of fat in the liver, arising from factors other than alcohol…
6 Mins
12 Sep 2019

Noninvasive Imaging Modalities in Nonalcoholic Fatty Liver Disease: Where Do We Stand?

New imaging modalities are emerging and may potentially replace biopsy. This review discusses the different noninvasive imaging modalities…
12 Mins
12 Sep 2019

Cholestasis in the Baby and Infant

Cholestasis is seen in every 2,500–5,000 live births. In full-term infants, jaundice that lasts >2 weeks should be evaluated; however, it should be…
11 Mins
12 Sep 2019

Primary Sclerosing Cholangitis: A Clinical Update

Primary sclerosing cholangitis (PSC) is a rare cholestatic disorder of the liver associated with inflammation and injury with fibrosis in the…
25 Jun 2019

Connection Observed Between Intrahepatic Cholestasis of Pregnancy and NAFLD

A STUDY has demonstrated a potential link between intrahepatic cholestasis of pregnancy (ICP) and non-alcoholic fatty liver disease (NAFLD)…
25 Jun 2019

Type 2 Diabetes Mellitus Patients at Higher Risk of Cirrhosis

LIFE-THREATENING cirrhosis and liver cancer are possible outcomes of conditions such as non-alcoholic fatty liver disease (NAFLD) and non-alcoholic…
3 Mins
28 May 2019

Transjugular Intrahepatic Portosystemic Stent-Shunt (TIPSS) for Acute Variceal Bleeding: Has it Come of Age?

Despite the introduction of covered TIPSS, studies have not consistently demonstrated a survival benefit in secondary prevention…
We’ve noticed you’re accessing
from North/South America.